Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm.

× No keyword cloud information.

8 in total

1. Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.

Authors: Christina B Duckworth; Linsheng Zhang; Shiyong Li
Journal: Int J Clin Exp Pathol Date: 2014-01-15

2. inv(2)(p23q13)/RAN-binding protein 2 (RANBP2)-ALK fusion gene in myeloid leukemia that developed in an elderly woman.

Authors: Yoshitomo Maesako; Kiyotaka Izumi; Satoshi Okamori; Kayo Takeoka; Chiyuki Kishimori; Atsuko Okumura; Gen Honjo; Takashi Akasaka; Hitoshi Ohno
Journal: Int J Hematol Date: 2013-12-04 Impact factor: 2.490

Review 3. The Fibroblast Growth Factor signaling pathway.

Authors: David M Ornitz; Nobuyuki Itoh
Journal: Wiley Interdiscip Rev Dev Biol Date: 2015-03-13 Impact factor: 5.814

4. A novel fusion of SQSTM1 and FGFR1 in a patient with acute myelomonocytic leukemia with t(5;8)(q35;p11) translocation.

Authors: Y Nakamura; Y Ito; N Wakimoto; E Kakegawa; Y Uchida; M Bessho
Journal: Blood Cancer J Date: 2014-12-12 Impact factor: 11.037

A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm.

1. Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case.

2. inv(2)(p23q13)/RAN-binding protein 2 (RANBP2)-ALK fusion gene in myeloid leukemia that developed in an elderly woman.

Review 3. The Fibroblast Growth Factor signaling pathway.

4. A novel fusion of SQSTM1 and FGFR1 in a patient with acute myelomonocytic leukemia with t(5;8)(q35;p11) translocation.

5. Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion.

Review 6. [Myeloid/lymphoid neoplasms with eosinophilia and FGFR1 rearrangement: 5 cases report and literatures review].

Review 7. The SUMO Pathway in Hematomalignancies and Their Response to Therapies.

8. Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway.